middle.news
How Is Genetic Signatures Turning Stable Revenue Into Global Growth?
8:30am on Thursday 26th of February, 2026 AEDT
•
Healthcare
Read Story
How Is Genetic Signatures Turning Stable Revenue Into Global Growth?
8:30am on Thursday 26th of February, 2026 AEDT
Key Points
Revenue steady at $8.7 million, driven by Australian respiratory testing and international markets
Net loss improved to $6.4 million, aided by cost discipline and R&D tax incentives
New US contracted customers onboarded, with a third expected to start testing soon
Ongoing NHS trust collaborations in the UK support infection control with GI test kits
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
GENETIC SIGNATURES (ASX:GSS)
OPEN ARTICLE